US2014194514A1PendingUtilityA1
Topical formulations
Est. expirySep 27, 2028(~2.2 yrs left)· nominal 20-yr term from priority
A61P 25/04A61P 25/02A61K 9/0014A61K 45/06A61K 31/135A61K 9/06A61K 31/18A61P 23/02A61K 47/44A61K 31/195
47
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Topical treatments for neuropathy are described. The treatments include topical formulations of NMDA antagonists and one additional active ingredient. In one example, the formulation includes ketamine and gabapentin for the treatment of a subject's neuropathy. These transdermal or topical compositions provide a surprising degree of effective relief from the symptoms of peripheral neuropathy and can be administered to subjects to treat various neuropathies.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A topical composition for the treatment of peripheral neuropathy comprising a therapeutically effective amount of at least one NMDA antagonist and only one additional active compound, wherein the composition is formulated in a pharmaceutically acceptable carrier for topical administration.Join the waitlist — get patent alerts
Track US2014194514A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.